Bioanalysis Zone

Biomarker validation, non-LBA assays and new technologies: an interview with Stephanie Traub


In this Bioanalysis Zone interview, Stephanie Traub (Cancer Research UK; London, UK) discusses her work as a biomarker specialist and the challenges she faces when developing biomarker strategies. Stephanie also explains the role of non-LBA assays for biomarker validation, before sharing what new technologies this field has seen in recent years.

If you enjoyed this interview, you might also like…

Leave A Comment